Y-590 (A new pyridazinone derivative), a potent anti-thrombotic agent — I. Effect on platelet function
- 1 August 1983
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 31 (4), 599-609
- https://doi.org/10.1016/0049-3848(83)90457-7
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Persantine and aspirin in coronary heart disease. The Persantine-Aspirin Reinfarction Study Research Group.Circulation, 1980
- Coronary Spasm and Acute Myocardial Infarction — New Possibility for Treatment and PreventionNew England Journal of Medicine, 1978
- Coronary Vasospasm as a Possible Cause of Myocardial InfarctionNew England Journal of Medicine, 1978
- Sulfinpyrazone in the Prevention of Cardiac Death after Myocardial InfarctionNew England Journal of Medicine, 1978
- Simple, sensitive fluorimetric assay for malondialdehyde production by blood plateletsThrombosis Research, 1977
- Controlled trial of aspirin in cerebral ischemia.Stroke, 1977
- HUMAN ARTERIAL AND VENOUS TISSUES GENERATE PROSTACYCLIN (PROSTAGLANDIN X), A POTENT INHIBITOR OF PLATELET AGGREGATIONThe Lancet, 1977
- Platelet Adhesiveness in von Willebrand’s DiseaseAmerican Journal of Clinical Pathology, 1969
- The aggregation of blood plateletsThe Journal of Physiology, 1963
- Fluorescence Characteristics of 5-Hydroxytryptamine (Serotonin)Science, 1955